Similar articles for PMID: 29146692

Year	Number of Results
2008	1
2009	3
2010	7
2011	8
2012	13
2013	5
2014	11
2015	15
2016	24
2017	23
2018	11
2019	10
2020	11
2021	12
2022	10
2023	7
2024	0

1

Prediction of ⁹⁰Y Radioembolization Outcome from Pretherapeutic Factors with Random Survival Forests.

Ingrisch M, Schöppe F, Paprottka K, Fabritius M, Strobl FF, De Toni EN, Ilhan H, Todica A, Michl M, Paprottka PM. Ingrisch M, et al. J Nucl Med. 2018 May;59(5):769-773. doi: 10.2967/jnumed.117.200758. Epub 2017 Nov 16. J Nucl Med. 2018. PMID: 29146692 Free article.

2

Pre-therapeutic factors for predicting survival after radioembolization: a single-center experience in 389 patients.

Paprottka KJ, Schoeppe F, Ingrisch M, Rübenthaler J, Sommer NN, De Toni E, Ilhan H, Zacherl M, Todica A, Paprottka PM. Paprottka KJ, et al. Eur J Nucl Med Mol Imaging. 2017 Jul;44(7):1185-1193. doi: 10.1007/s00259-017-3646-z. Epub 2017 Feb 14. Eur J Nucl Med Mol Imaging. 2017. PMID: 28197686

3

⁹⁰Y Radioembolization for Locally Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis: Long-Term Outcomes in a 185-Patient Cohort.

Abouchaleh N, Gabr A, Ali R, Al Asadi A, Mora RA, Kallini JR, Mouli S, Riaz A, Lewandowski RJ, Salem R. Abouchaleh N, et al. J Nucl Med. 2018 Jul;59(7):1042-1048. doi: 10.2967/jnumed.117.199752. Epub 2017 Dec 7. J Nucl Med. 2018. PMID: 29217739 Free article.

4

Predictive value of intratumoral 99mTc-macroaggregated albumin uptake in patients with colorectal liver metastases scheduled for radioembolization with 90Y-microspheres.

Ulrich G, Dudeck O, Furth C, Ruf J, Grosser OS, Adolf D, Stiebler M, Ricke J, Amthauer H. Ulrich G, et al. J Nucl Med. 2013 Apr;54(4):516-22. doi: 10.2967/jnumed.112.112508. Epub 2013 Feb 27. J Nucl Med. 2013. PMID: 23447653 Free article.

5

90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study.

Hickey R, Lewandowski RJ, Prudhomme T, Ehrenwald E, Baigorri B, Critchfield J, Kallini J, Gabr A, Gorodetski B, Geschwind JF, Abbott A, Shridhar R, White SB, Rilling WS, Boyer B, Kauffman S, Kwan S, Padia SA, Gates VL, Mulcahy M, Kircher S, Nimeiri H, Benson AB, Salem R. Hickey R, et al. J Nucl Med. 2016 May;57(5):665-71. doi: 10.2967/jnumed.115.166082. Epub 2015 Dec 3. J Nucl Med. 2016. PMID: 26635340 Free article.

6

Radioembolization with (90)Y resin microspheres for intrahepatic cholangiocellular carcinoma: prognostic factors.

Soydal C, Kucuk ON, Bilgic S, Ibis E. Soydal C, et al. Ann Nucl Med. 2016 Jan;30(1):29-34. doi: 10.1007/s12149-015-1026-y. Epub 2015 Sep 14. Ann Nucl Med. 2016. PMID: 26370716

7

Safety, Efficacy, and Prognostic Factors After Radioembolization of Hepatic Metastases from Breast Cancer: A Large Single-Center Experience in 81 Patients.

Fendler WP, Lechner H, Todica A, Paprottka KJ, Paprottka PM, Jakobs TF, Michl M, Bartenstein P, Lehner S, Haug AR. Fendler WP, et al. J Nucl Med. 2016 Apr;57(4):517-23. doi: 10.2967/jnumed.115.165050. Epub 2016 Jan 7. J Nucl Med. 2016. PMID: 26742710 Free article.

8

Lung Shunt Fraction prior to Yttrium-90 Radioembolization Predicts Survival in Patients with Neuroendocrine Liver Metastases: Single-Center Prospective Analysis.

Ludwig JM, Ambinder EM, Ghodadra A, Xing M, Prajapati HJ, Kim HS. Ludwig JM, et al. Cardiovasc Intervent Radiol. 2016 Jul;39(7):1007-14. doi: 10.1007/s00270-016-1323-4. Epub 2016 Mar 10. Cardiovasc Intervent Radiol. 2016. PMID: 26964779

9

Bi-Centric Independent Validation of Outcome Prediction after Radioembolization of Primary and Secondary Liver Cancer.

Fabritius MP, Seidensticker M, Rueckel J, Heinze C, Pech M, Paprottka KJ, Paprottka PM, Topalis J, Bender A, Ricke J, Mittermeier A, Ingrisch M. Fabritius MP, et al. J Clin Med. 2021 Aug 19;10(16):3668. doi: 10.3390/jcm10163668. J Clin Med. 2021. PMID: 34441964 Free PMC article.

10

Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization.

Camacho JC, Kokabi N, Xing M, Prajapati HJ, El-Rayes B, Kim HS. Camacho JC, et al. J Vasc Interv Radiol. 2014 Feb;25(2):256-65. doi: 10.1016/j.jvir.2013.10.056. J Vasc Interv Radiol. 2014. PMID: 24461131

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

149 results

Results by year